Clinical Trials Logo

Clinical Trial Summary

The study will evaluate myocardial inflammation in cyclists after high intense and sustained exercise. Our hypothesis is that strenuous exercise in recreational cyclists may be associated with myocardial inflammation. Myocardial fibrosis in asymptomatic athletes is associated with life-threatening arrhythmic events and sudden death. Although myocarditis seems to be the most likely underlying cause, it remains unclear if strenuous and sustained physical exercise can cause myocardial inflammation with development of myocyte necrosis and possibly myocardial fibrosis in athletes. Nineteen recreational cyclists performing "L'ETAPE DU TOUR (EDT) de France" a cycling ride (175 km, 3600 m of positive altitude difference) on July 4 2021 will be included in this study. Each participant will complete a detailed questionnaire detailing their training history. All participants will have exercise testing approximately 1 week before the EDT stage to set aerobic and anaerobic gas exchange thresholds, as well as VO2max. In part 2 of the study cardiac MRI will be performed at rest before the EDT cycling ride completion. An ECG registration using a RootiRx will be realized during and up to 6 hours after the cycling ride. An echocardiography and cardiac MRI will be repeated in each cyclist between 3 and 6 hours after EDT cycling ride completion. A blood sample will be obtained at that time after the ride. This time point is chosen based on the highest troponin release that 3 to 6 hours post-exercise would allow a sufficient amount of time for inflammation to develop and be detectable, corresponding with the time when cardiac Troponin T is typically detectable and representing the liberation of enzymes from damaged myocytes. Finally, a third cardiac MRI will be repeated 24 hours after start of the cycling ride to verify the evolution of possible inflammation over this time period.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05138003
Study type Interventional
Source Jessa Hospital
Contact
Status Completed
Phase N/A
Start date July 1, 2021
Completion date October 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT03607071 - Outcome of Steroid Therapy for Myocardial Inflammation in Scleroderma Phase 2
Completed NCT04322630 - Mer-TK in Human Cardiac Cells
Completed NCT03776682 - Myocardial Inflammation in Rheumatoid Arthritis: A Descriptive Study
Completed NCT04940650 - COUREUR Study Myocardial Inflammation in Cyclist Part 1 N/A
Terminated NCT03619876 - Effects of Abatacept on Myocarditis in Rheumatoid Arthritis Phase 4
Completed NCT03782259 - Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2 Phase 4
Recruiting NCT03525639 - CMR Evaluation of Myocardial Inflammation Persistence After Acute Myocarditis: Prognostic Relevance N/A
Terminated NCT03103490 - 18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation Phase 2
Completed NCT04437927 - Impact of 100mL Lipid Emulsion for Intravenous for Suppression of Myocardial Glucose Metabolism in 18F-FDG PET/CT
Recruiting NCT05519735 - Lymphatic Organs and Myocardium After Myocardial Infarction N/A